413 related articles for article (PubMed ID: 12365022)
1. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
[TBL] [Abstract][Full Text] [Related]
5. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
Halmos G; Schally AV; Bernardino AL; Varga JL
Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
Szepeshazi K; Schally AV; Groot K; Armatis P; Halmos G; Herbert F; Szende B; Varga JL; Zarandi M
Br J Cancer; 2000 May; 82(10):1724-31. PubMed ID: 10817510
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
Kahán Z; Varga JL; Schally AV; Rékási Z; Armatis P; Chatzistamou L; Czömpöly T; Halmos G
Breast Cancer Res Treat; 2000 Mar; 60(1):71-9. PubMed ID: 10845811
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells.
Scheven BA; Hamilton NJ; Fakkeldij TM; Duursma SA
Growth Regul; 1991 Dec; 1(4):160-7. PubMed ID: 1842348
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Bajo AM
J Cancer Res Clin Oncol; 2001 Nov; 127(11):645-52. PubMed ID: 11710593
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.
Friend KE; Khandwala HM; Flyvbjerg A; Hill H; Li J; McCutcheon IE
Growth Horm IGF Res; 2001 Apr; 11(2):84-91. PubMed ID: 11472074
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro.
Sacewicz M; Lawnicka H; Siejka A; Stepień T; Krupiński R; Komorowski J; Stepień H
Cancer Lett; 2008 Sep; 268(1):120-8. PubMed ID: 18486324
[TBL] [Abstract][Full Text] [Related]
16. The monoclonal HBA-71 antibody modulates proliferation of thymocytes and Ewing's sarcoma cells by interfering with the action of insulin-like growth factor I.
Hamilton G; Mallinger R; Hofbauer S; Havel M
Thymus; 1991 Aug; 18(1):33-41. PubMed ID: 1656551
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
Kiaris H; Schally AV; Varga JL
Cancer Lett; 2000 Dec; 161(2):149-55. PubMed ID: 11090963
[TBL] [Abstract][Full Text] [Related]
18. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression patterns for GH, PRL, SL, IGF-I and IGF-II during altered feeding status in rabbitfish, Siganus guttatus.
Ayson FG; de Jesus-Ayson EG; Takemura A
Gen Comp Endocrinol; 2007 Jan; 150(2):196-204. PubMed ID: 16978626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
